Clinical Trial Update: Trastuzumab in Treating Patients With Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update showing trastuzumab in prostate cancer has completed; the study status is listed as COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• HERCEPTIN (trastuzumab)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED